Literature DB >> 9223156

Paramyosin: a candidate vaccine antigen against Schistosoma japonicum.

B L Ramirez1, J D Kurtis, P M Wiest, P Arias, F Aligui, L Acosta, P Peters, G R Olds.   

Abstract

Paramyosin, a 97 kDa myofibrillar protein, is a candidate vaccine antigen for prevention of infection with the human parasite Schistosoma mansoni. To determine if paramyosin would also induce protection against Schistosoma japonicum, paramyosin was biochemically purified from S. japonicum adult worms. SDS-PAGE demonstrated a single protein with a molecular weight of 97 kDa. In four separate experiments, vaccination of mice with S. japonicum paramyosin without adjuvant induced significant resistance (62%-86%, P < 0.001) against cercarial challenge as compared to controls. These data suggest that S. japonicum paramyosin may represent a candidate vaccine for immunization against schistosomiasis japonica.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9223156     DOI: 10.1046/j.1365-3024.1996.d01-4.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  20 in total

1.  Construction, purification, and evaluation of multivalent DNA vaccine against Schistosoma japonicum.

Authors:  Lu Zhu; Hai-Feng Liu; Ming-Bo Lu; Quan-Ke Long; You-En Shi; Long-Jiang Yu
Journal:  Parasitol Res       Date:  2010-09-18       Impact factor: 2.289

2.  T-helper-2 cytokine responses to Sj97 predict resistance to reinfection with Schistosoma japonicum.

Authors:  Tjalling Leenstra; Luz P Acosta; Hai-Wei Wu; Gretchen C Langdon; Julie S Solomon; Daria L Manalo; Li Su; Mario Jiz; Blanca Jarilla; Archie O Pablo; Stephen T McGarvey; Remigio M Olveda; Jennifer F Friedman; Jonathan D Kurtis
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  Vaccination with recombinant paramyosin in Montanide ISA206 protects against Schistosoma japonicum infection in water buffalo.

Authors:  Hannah Wei Wu; Zhi-Qiang Fu; Ke Lu; Sunthorn Pond-Tor; Rui Meng; Yang Hong; Kai Chu; Hao Li; Mario Jiz; Jin-Ming Liu; Ming Hou; Sangshin Park; Jiao-Jiao Lin; Jonathan D Kurtis
Journal:  Vaccine       Date:  2017-05-11       Impact factor: 3.641

4.  Differential antigen-stimulated proliferation of human mononuclear cells by recombinant Schistosoma japonicum antigens in a Chinese population.

Authors:  G J Waine; W Yang; A G Ross; Y S Li; A C Sleigh; B H Kalinna; J C Scott; D Mazzer; Y Li; D P McManus
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

5.  The immunodominant Brugia malayi paramyosin as a marker of current infection with Wuchereria bancrofti adult worms.

Authors:  S Langy; C Plichart; P Luquiaud; S A Williams; L Nicolas
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

6.  Characterization and protective potential of the immune response to Taenia solium paramyosin in a murine model of cysticercosis.

Authors:  J Vázquez-Talavera; C F Solís; L I Terrazas; J P Laclette
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

7.  Molecular cloning and characterization of a paramyosin from Clonorchis sinensis.

Authors:  Tae-Joon Park; Jung-Mi Kang; Byoung-Kuk Na; Woon-Mok Sohn
Journal:  Korean J Parasitol       Date:  2009-12-01       Impact factor: 1.341

8.  Inhibition of the complement membrane attack complex by Schistosoma mansoni paramyosin.

Authors:  Jiusheng Deng; Daniel Gold; Philip T LoVerde; Zvi Fishelson
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

9.  Cloning and characterization of Taenia saginata paramyosin cDNA.

Authors:  Elizabeth Ferrer; Eva Moyano; Laura Benitez; Luis Miguel González; Denise Bryce; Mildred Foster-Cuevas; Iris Dávila; Maria Milagros Cortéz; Leslie J S Harrison; R Michael E Parkhouse; Teresa Gárate
Journal:  Parasitol Res       Date:  2003-07-25       Impact factor: 2.289

10.  Pilot-scale production and characterization of paramyosin, a vaccine candidate for schistosomiasis japonica.

Authors:  Mario Jiz; Hai-Wei Wu; Rui Meng; Sunthorn Pond-Tor; Mindy Reynolds; Jennifer F Friedman; Remigio Olveda; Luz Acosta; Jonathan D Kurtis
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.